Q32 Bio Inc. (QTTB) Stock Overview
Explore Q32 Bio Inc.’s financial performance, market position, analyst ratings, and future outlook.
Q32 Bio Inc. (QTTB)
Key Financials
Key Financials
Market Cap
332.5M
P/E Ratio
3.94
EPS (TTM)
$2.07
ROE
0.77%
QTTB Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Q32 Bio Inc. (NASDAQ: QTTB) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Q32 Bio Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of QTTB on the NASDAQ shows an RSI of 30.61, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Q32 Bio Inc.'s NASDAQ-traded stock include a P/E ratio of 3.94 and a market capitalization of 332.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of QTTB on the NASDAQ.